POLICY / ELIGIBILITY
Purchase Eligibility Policy
Effective August 16, 2026 · Current release
Independent account and product review
Transaction eligibility is determined separately for each buyer, product, lot, destination, and channel. Catalog presence or RFQ submission does not itself authorize a transaction.
No automatic approval
Form submission, account review, supplier evidence, successful testing, a QR route, catalog presence, a competitor sale, or prior order does not by itself authorize a transaction.
Product decisions
Product availability is limited to the payment methods and destinations supported by our current review. Missing, expired or withdrawn decisions prevent payment access and shipment, even if a lot is in stock. Payment-provider acceptance does not establish FDA approval or replace applicable legal requirements.
Reorders
A reorder must re-evaluate the then-current exact lot, COA, availability, destination, account, and transaction controls. Prior approval cannot be recycled across lots or channels.